Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 274 No 7341 p329
19 March 2005

This article
Reprint   Photocopy

  Acrobat Reader


News summary


People with vascular disease or diabetes should not use vitamin E supplements

Vitamin E supplements should not be used by people with vascular disease or diabetes, according to the authors of a new study.

They make their recommendation after finding that use of vitamin E supplements appears to increase the risk of heart failure. The researchers examined the long-term effects of supplementation in an extension to the HOPE (heart outcomes prevention evaluation) trial, in which participants were randomised to receive a 400IU daily dose of vitamin E or placebo.

After seven years of follow up, the researchers found no evidence that vitamin E protected against cancer or major cardiovascular events. What is more, patients given vitamin E supplements were found to have an increased risk of heart failure (relative risk 1.13, 95 per cent confidence interval 1.01–1.26, P=0.03) and an increased risk of being admitted to hospital with heart failure (1.21, 1.00–1.47, P=0.045).

The researchers acknowledge that the finding could be due to chance but say that the excess in heart failure events among participants taking vitamin E was a “robust and consistent” finding in the study.

They recommend that a review of heart failure events in previous trials of vitamin E should be conducted (JAMA 2005;293:1338).

Back to Top


©The Pharmaceutical Journal